eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | non-alcoholic fatty liver disease |
| Comorbidity | C0020456|hyperglycemia |
| Sentences | 5 |
| PubMedID- 21886908 | T2dm is commonly associated with dyslipidemia and hyperglycemia in nafld patients [7, 16]. |
| PubMedID- 22927782 | Insulin resistance in nafld is frequently associated with chronic hyperinsulinemia, hyperglycemia, and an excessive supply of plasma free fatty acids to the liver. |
| PubMedID- 23583988 | The nafld patients with hyperglycemia were further divided into the isolated impaired fasting glucose (i-ifg) and postprandial hyperglycemia subgroups. |
| PubMedID- 24339864 | Considering that we observed significant sfrp1 dependent changes in the gluconeogenic transcripts in the liver, and non-alcoholic fatty liver disease is tightly associated with obesity and hyperglycemia [31], we chose to examine the effects of a hfd in the livers of these mice. |
| PubMedID- 25844093 | This suggests that insulin resistance could be amplified in nafld patients with hyperglycemia, which may be associated with the presence of coronary atherosclerosis. |
Page: 1